E. Wicklein

发表

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry

Ludwig Kappos, Till Sprenger, Stefan Klöppel, 2018, Brain Imaging and Behavior.

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b

Dawn Langdon, Anthony L Traboulsee, Marcelo Kremenchutzky, 2019, Multiple sclerosis.

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

F. Barkhof, X. Montalban, L. Kappos, 2022, Multiple sclerosis.

Clinical and molecular genetic spectrum of autosomal dominant Emery‐Dreifuss muscular dystrophy due to mutations of the lamin A/C gene

E. Mercuri, K. Bushby, F. Muntoni, 2000, Annals of neurology.

Sensitivity and specificity of different conduction block criteria

G. Pfeiffer, E. Wicklein, K. Wittig, 2000, Clinical Neurophysiology.

Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11) (P7.012)

David H. Miller, F. Barkhof, X. Montalban, 2015 .

Missense mutation ( R 15 W ) of the connexin 32 gene in a family with X chromosomal Charcot-Marie-Tooth neuropathy with only female family members a V ected

K. Kunze, A. Gal, E. Wicklein, 1998 .

Missense mutation (R15W) of the connexin32 gene in a family with X chromosomal Charcot-Marie-Tooth neuropathy with only female family members affected

K. Kunze, A. Gal, E. Wicklein, 1997, Journal of neurology, neurosurgery, and psychiatry.

Molecular diagnosis of McArdle disease: Revised genomic structure of the myophosphorylase gene and identification of a novel mutation

C. Kubisch, T. Jentsch, E. Wicklein, 1998 .

Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study

F. Patti, E. Wicklein, Javier Nicolas Penaherrera, 2021, BMC Neurology.

Vitamin D, smoking, EBV, and long-term cognitive performance in MS

X. Montalban, L. Kappos, H. Hartung, 2020, Neurology.

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

F. Barkhof, X. Montalban, L. Kappos, 2016, Neurology.

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

P. Huppke, A. Ornoy, R. Weitzman, 2020, Journal of Neurology.

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

Till F. M. Andlauer, F. Barkhof, M. Filippi, 2019, Multiple sclerosis.

Nonsense mutations in SMPX, encoding a protein responsive to physical force, result in X-chromosomal hearing loss.

F. Wagner, P. Frommolt, G. Nürnberg, 2011, American journal of human genetics.

Disability and quality of life in Charcot-Marie-Tooth disease type 1

K. Kunze, G. Pfeiffer, E. Wicklein, 2001, Journal of neurology, neurosurgery, and psychiatry.

Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT® Autoinjector: A Retrospective Cohort Study

K. Holl, E. Wicklein, A. Frenz, 2021, Drugs - Real World Outcomes.

Sodium intake and multiple sclerosis activity and progression in BENEFIT

X. Montalban, L. Kappos, H. Hartung, 2017, Annals of neurology.

Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure

E. Wicklein, K. Hellwig, A. Adamo, 2020, Therapeutic advances in neurological disorders.

Title : Sodium intake and multiple sclerosis activity and progression in BENEFIT Running Head : No link between sodium and MS outcomes

Scd, X. Montalban, L. Kappos, 2017 .

Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation.

C. Kubisch, T. Jentsch, E. Wicklein, 1998, Human mutation.

Prominent sensory ataxia in Guillain–Barré syndrome associated with IgG anti-GD1b antibody

K. Kunze, N. Yuki, G. Pfeiffer, 1997, Journal of the Neurological Sciences.

Reports of Patients and Relatives from the CogniCIS Study about Cognition in Clinically Isolated Syndrome: What Are Our Patients Telling Us?

D. Langdon, S. Fredrikson, K. Beckmann, 2013, European Neurology.